1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
644626A1F91B93867852573F00070DC59
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-in-creating-value-through-continuing-medical-education?opendocument
18
19opendocument
2054.226.58.177
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services ╗

Best Practices in Creating Value Through Continuing Medical Education

ID: PSM-223


Features:

17 Info Graphics

25 Data Graphics

250 Metrics

80 Narratives

14 Best Practices


Pages: 78


Published: Pre-2013


Delivery Format: Shipped


 

License Options:

close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • VIEW TOC AND LIST OF EXHIBITS
With limited information on actual return on investment for expenditures toward support of Continuing Medical Education activities, Pharmaceutical and Biotechnology companies are anxious to understand the value of CME support and strategies for ensuring investments provide appropriate impact on healthcare practitioner behaviors and patient outcomes. With this understanding, this study was undertaken utilizing key benchmark metrics and executive insights to assess current trends and future directions of CME in North America and Europe to map a path to future success in support of CME.

Industries Profiled:
Biotech; Pharmaceutical; Medical Device; Health Care; Chemical


Companies Profiled:
Alcon Laboratories; Sanofi-aventis; Talecris; Sepracor; Roche; Pfizer; Ortho-Clinical Diagnostics; Novo Nordisk; Novartis Canada; Serono; Merck; Johnson & Johnson; Genentech; Eli Lilly and Company; Daiichi Pharmaceutical Co.; Ltd.; Celgene; Bristol-Myers Squibb; Boehringer Ingelheim; Baxter Healthcare; AstraZeneca; Amylin


Study Snapshot

This research was based on benchmark survey data and executive interviews of 30 participants from 26 pharmaceutical, biotechnology and medical education companies.

Key topics include:
  • What is the current landscape of continuing medical education (CME) in North America and Europe?
  • What structural forms are used to deploy CME, optimize budgets & best deliver content?
  • How rapidly is E-CME advancing?
  • What CME delivery channels are preferred?
  • What are the current trends and future directions of CME?
Table of Contents

RESEARCH BACKGROUND 3
Research Objective and Methodology 4
Universe of Learning: North American Participants 5
Universe of Learning: European Participants 6
Universe of Learning: CME Vendors 7
Insights Span the Global Bio-Pharma Market 8
Participants Oversee Diverse CME Functions 9

SUMMARY OF KEY FINDINGS, INSIGHTS AND TRENDS 10
Insight #1: Decentralized CME Structures Prevail 11
Insight #2: CME Internet Usage is Accelerating 12
Insight #3: Balance Resources, Market Reach and Quality 13
Insight #4: Accelerating CME Evolution 14
Insight #5: First-line Management Tools Benefit CME 15

CURRENT CME STRUCTURAL TRENDS 16
Three Epicenters of Accredited CME Span the Globe 17
Two Epicenters (North America & EU Big 5) Drive CME 18
Decentralized CME Structures Proliferate 19
Snapshot Europe: Structural Models 20
The Centralized Model Efficiently Broadcasts CME to Markets 21
Decentralized Models Look to Each Market for CME Leadership 22
Hub-&-Spokes Models Blend Centralization & Local Market Autonomy 23

LEVERAGING BUDGETARY RESOURCES 24
CME Investment Levels Vary Greatly Across Countries 25
Balance Planned & Spontaneous CME Programs 26
Engage CME Practice Communities to Accelerate Learning 27

CME EVOLUTION MODELS 28
Change Models are Being Applied to CME 29
Targeting CME for Change-Ready Physicians 30
New Formula Emerging to Optimize CME Impact 31
Improving CME Performance Impact 32
Snapshot Europe: Accelerated Evolution 33
Requirements for CME in Europe 34
Language & Learning Models Vary Across EU 35

CME FUNCTIONAL MANAGEMENT 36
Medical Affairs & Communications commonly have CME Oversight 37
North American CME Distribution Channels also centrally Managed 38
European CME Distribution Channels are Managed thru One Group 39
Medical Affairs & Grants Groups Lead North American CME 40
Marketing & Medical Functions Lead European CME 41

BUILDING TALENT DEPTH, BREADTH & COMPETENCE 42
Medical Affairs & Communications are CME Training Grounds 43
Develop a CME Strategy to Best Manage Limited Resources 44
CME Staff Tenure and Hiring Requirements 45
CME Staffing Levels Vary Greatly Across Markets 46
Building CME Talent is a Key Need in Europe 47

OPTIMIZING CME DELIVERY CHANNELS 48
Face-to-Face & E-CME Dominate in North America 49
Face-to-Face Delivery is Dominant in Europe 50
Use Assessments to Set CME Strategic Agenda 51
Snapshot Europe: CME Delivery Channels 52
Divining Optimal Channel Mix for European Market 53

CULTIVATING E-LEARNING 54
Internet is Growing in Relevance as a Delivery Mechanism 55
Snapshot Europe: E-Learning 56
Long-Distance Learning is Seeded & Growing 57
E-CME Delivery in Europe & North America 58

CME CONTENT MANAGEMENT 59
Symposia are Most Effective European CME Services 60
Clinical Cases are Preferred CME Form in North America 61
Field-based Assessments reveal the state of
Clinical Practice in the Local Market 62
Third-Party Vendors Deliver most European CME 63
Third-Party Vendors also Dominate N.A. CME Delivery 64

CME LESSONS LEARNED 65
Leading Indicators of Change for CME 66
CME Delivery Modes: E-CME 67
CME Delivery Modes: Face-to-Face Meetings 68
CME Delivery Modes: Enduring Materials & TCs 69
Differentiating CME Offerings 70
Snapshot Europe: CME Lessons Learned 71
Delivering CME Excellence in Europe 72
CME Improvement Opportunities – Voices from the Field 74

APPENDIX 76
Definitions of Statistical Data 77
About Best Practices, LLC 78

Sample List of Charts & Exhibits

Geographic delivery of CME
  • Structural management of CME
  • CME investment budgets for North America
  • CME investment budgets for Europe
  • CME investment staffing for North America
  • CME investment staffing for Europe
  • Mix of planned versus spontaneous CME investment
  • Functional responsibility for CME
  • Mix of CME delivery in North America (company directed versus 3rd party, etc.)
  • Mix of CME delivery in Europe
  • Background & experience of CME employees
  • Tenure of CME employees
  • Mix of CME delivery modes for North America
  • Mix of CME delivery modes for Europe
  • Use of E-CME in North America & Europe
  • Effectiveness ratings for CME delivery activities in North America
  • Effectiveness ratings for CME delivery activities in Europe